CSIR-CDRI Lucknow

Director's Message

The Central Drug Research Institute (CDRI) is a constituent laboratory of the Council of Scientific and Industrial Research (CSIR) under the Department of Scientific & Industrial Research, Ministry of Science and Technology, Government of India.

Notice for schedule of Trade Test and written examination for the post of Technical Assistant, Post Codes TA07, TAO8, TA09, TA10, TA11, TA12, TA13, TA15 & TA16 against Advt. No.11/2020 New
Result for the position PROJECT STAFF against Advt. no. 03/2025New
Result for the position code 009 (PROJECT STAFF) against Advt. no. 08/2024New
Link for Downloading marks obtaind in the written examination for the post of Technician (1), Post Code TN03 and TN06 against Advt. No. 11/2020New
Cancellation of the position of Project Technical Support-III (position code 06) online mode against advt. no. 06/2024New
Result for recruitment to the posts of Technician (1), Post Code TN03 (S&T Management) and Post Code TN06 (Electric Services) against Advertisement No. 11/2020New
Access link to apply for Jr. Secretariat Assistant (Gen./F&A/S&P) and Jr. Stenographer (Hindi/English) Recruitment-2025 (Advt NO. CSIR-CDRI/02/2025) New
Result of PROJECT STAFF against Advt. no. 01/2025 New
Notice regarding cancellation of the position of Project Associate-I against Advt No. 03(P17)/2024New
Result of PROJECT STAFF against Advt. no. 08/2024 for Position Code 001New
Result of PROJECT STAFF against Advt. no. 03(P06)/2024New
Provisional Answer keys of Written Examination held on 25.01.2025 for the Post of Technician (1) Post Code TN-03 and TN-06 vide Advertisement No. 11/2020New
Result of the Trade Test for the Post of Technician (1), Post Code TN03 in the Area of S&T Management & Post code TN 06 in the area of Electric Services advertised vide Advertisement No. 11/2020New
Result of Project Staff against Advt. no. 03(P12)/2024 New
Result of PROJECT STAFF against Advt. no. 03(P28)/2024New
Notice No. 5(25)/2024-Estt.I (Tech.) dated 15.01.2025 for cancellation of the post of Technician (1), Post Code T11 & T12 in the area of Centralized Utility Services (CUS) New
Download ADMIT CARD for the Post of TECHNICIAN (1) for Post Code TN03 and TN06 against Advt No: 11/2020 New
SCIENTIST RECRUITMENT Advt No- 09/2024 New
Notice No. 5(25)/2017-Estt.I/Tech(1)/(11/2020) for eligible candidates for the Post of Technician(1), Post Code TN03 and TN06 against Advt. no. 11/2020 New
Result of the position of PROJECT STAFF (LIFE SCIENCES) against Advt. no. 08/2024 New
Notice reg: Cancellation of the position of Senior Project Associate against advt. no. 03(P29)/2024 New
Shortlisted Candidates for Project Associate-I (Position Code-06) against Advt. No. 06/2024 New
Result of the position of Project Associate (PAT-I) against Advt. no. 07/2024(PC001) online. New
Result of the position code 013, 014, 015, 017 & 018 against Advt.no. 08/2024
Notice reg. 5(25)/2020-Estt.I/Tech(1)/(11/2020) against Advt no. 11/2020
Result of the position of Project Associate-I against Advt. no. 07/2024(PC002) online
Updated list of candidates who have fulfilled the eligibility criteria for Trade Test and list of rejected candidates with reason and hard copy of applications not received by 22.02.2021 for the posts of Technician (1), Post Code TN03 in the area of S&T Management & Post Code TN06 in the area of Electric Services
Cancellation of the position of Project Associate-I against advt. no. 03(P07)/2024

Tenders

Vacancies

Admissions

Advertisement of CSIR-CDRI-AcSIR Ph.D. Program (August 2025) [Last Date: 14th April,2025] New

Commercialized Products

Reunion ( Dalzbone )

Success Story of Development of New Herbal Medication for Bone Health.

Dalbergia sissoo, (popularly known as sheesham) was found to contain novel osteogenic compound, caviunin-7-O-[β-D-apiofuranosyl-(1→6)-β-D glucopyranoside (CAFG).
CAFG increased production of bone morphogenetic protein-2 by osteoblasts and chondrocytes via the stimulation of canonical Wnt pathway, which is a clinically validated osteogenic pathway.
The bone anabolic effect of the extract was observed at an oral dose of 250mg/kg/day.

E-MAL ( Arteether )

For cerebral malaria as a second line treatment for chloroquine resistant cases, licensed to Themis Chemicals Ltd., Mumbai in 1997.

Arteether is a semi-synthetic derivative of artemisinin, the active constituent of the plant, Artemisia annua.
It is found to be safe and also fast acting, blood schizontocidal agent which attacks at the erythrocytic stage of malaria in blood.
Arteether has been jointly developed by CSIR-CDRI & CSIR-CIMAP and is being prescribed to the patients as second line of treatment for chloroquine-resistant P. falciparum malaria including cerebral malaria.

Saheli ( Centchroman )

First non steroidal female oral contraceptive Licensed to HLL Lifecare Ltd., in 1992 & being marketed as SAHELI.

first in the world non-steroidal oral contraceptive pill.
The only anti-implantation agent approved for clinical use in the world.
Offers a unique combination of weak estrogenic and potent anti-estrogenic properties.
It is also indicated for Uterine dysfunction, Mastalgia, Fibroadenoma and as Emergency contraceptive.

KeenMind ( Bacopa Extract)

Keenmind is marketed through Soho Flordis International, Sydney, Australia .

CSIR-CDRI developed a formulation of enriched Bacopa extract (BESEB).
It is a clinically proven natural product which improves memory, learning, concentration.
This has anti-oxidant, anti-stress & anti-anxiety properties. BESEB is recommended for ADHD children & AAMI in elderly subjects.

Joint Fresh

Standardized nano-formulation from Spinacea oleracea commonly known as Palak for osteoarthritis.

Technology Licensed to Pharmanza Herbals Pvt. Ltd.
Spinacia has the ability to lay more cartilage cells and thus resulted in cartilage protective effects.
Histological, radiological and micro CT analysis of knee joints showed improvement in the joint space and improved irregularity of the articular and atrophied femoral condyles and tibial plateau.
Reduces the osteophyte formation and thus pain reduction with improvement in walking ability.

Research Highlights

Metabolic Disorders

The study identifies the novel action of Withaferin A, a naturally occurring molecule derived from Ashwagandha (Withania somifera, (L.) Dunal) in protecting bones from high fat diet induced changes. Oral administration of the Withaferin A was found active.

Parasitic Infections

The study identifies an apicoplast-targeted exonuclease (PfExo) in Plasmodium falciparum with a unique LCR insertion that expands its substrate range and is essential for apicoplast DNA replication. The insertion enhances PfExo 's functionality compared to its rodent ortholog, underscoring its c...

Neurological Disorders

Oral administration of CSP-TTK21 in mice and rats induces long-term potentiation and improves motor function and regeneration-associated gene expression in spinal injury models, matching the efficacy of intraperitoneal administration without toxicity.

Cancer

Mantle cell lymphoma is an incurable subtype of B-cell lymphoma which is very heterogeneous. This study identified a few MCL cells adhered to stromal cells have cancer stem cell-like (CSCs) characteristics and expresses high level of lncRNA “CERS-AS1” which regulates oncogenic signaling by stabilizi...